ABCC7 p.Thr351Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 11927667
[PubMed]
Gong X et al: "Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore."
No.
Sentence
Comment
82
Two other mutants were also transfected into BHK cells; however, even in the presence of PPi, currents carried by R334A and T351A were too small for proper analysis (not shown).
X
ABCC7 p.Thr351Ala 11927667:82:124
status: NEW154 Unfortunately, we were unable to test the role of TM6 residues more intracellular than I344 on anion binding; R347 was not studied because of its association with pore stability (Cotten & Welsh, 1999), T351A was not well expressed in BHK cells and the blocking effects of Au(CN)2 _ on R352Q most likely do not reflect open channel block.
X
ABCC7 p.Thr351Ala 11927667:154:202
status: NEW
PMID: 22160394
[PubMed]
Cui G et al: "Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers."
No.
Sentence
Comment
151
The surprising finding that mutations at six adjacent positions Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT ** ** ** ** ** ** * * * 0.8 0.6 0.4 0.2 0 Fractional block by Glyb50 μM Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT ** ** ** ** ** ** ** ** * * * * * * ** ** Fractional block by Tolb300 μM 0.8 0.6 0.4 0.2 0 Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT * ** ** ** ** ** ** ** ** Fractional block by Glip200 μM 0.8 0.6 0.4 0.2 0 Fig. 3 Alanine-scanning in TM6 to identify the amino acids that interact with the three blockers.
X
ABCC7 p.Thr351Ala 22160394:151:76
status: NEWX
ABCC7 p.Thr351Ala 22160394:151:277
status: NEWX
ABCC7 p.Thr351Ala 22160394:151:497
status: NEW166 Double asterisks indicate significantly different compared to WT-CFTR (p<0.01) Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT 0.3 0.2 0.1 0 * * ** ** 0.4 Initial block by 50 μM Glyb Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT 0.4 0.3 0.2 0.1 0 ** ** * Initial block by 200 μM Glip Fig. 5 Initial block of WT-CFTR and selected TM6 mutants by 50 μM Glyb (left) and 200 μM Glip (right) in symmetrical 150 mM Cl- solution. Data are shown only for those mutants which exhibited significant changes in steady-state fractional block according to Fig. 3 (bars show mean±SEM, n=5-10).
X
ABCC7 p.Thr351Ala 22160394:166:91
status: NEWX
ABCC7 p.Thr351Ala 22160394:166:276
status: NEW193 Probable orientation of drugs in the pore Glyb and Glip are identical molecules along most of their lengths, differing only in the substituents on the ring at the Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT 0.8 0.6 0.2 0 ** ** ** ** Time-dependent block by 50 μμM Glyb Q353A R352A T351A V350A A349S M348A R347A L346A V345A I344A C343A F342A S341A I340A T339A T338A F337A I336A K335A R334A WT ** ** * ** * Time-dependent block by 200 μM Glip 0.4 0.8 0.6 0.2 00.4 Fig. 6 Time-dependent block of WT-CFTR and selected TM6 mutants by 50 μM Glyb (left) and 200 μM Glip (right) in symmetrical 150 mM Cl- solution. Data are shown only for those mutants which exhibited significant changes in fractional block according to Fig. 3 (bars show mean±SEM, n=5-10).
X
ABCC7 p.Thr351Ala 22160394:193:175
status: NEWX
ABCC7 p.Thr351Ala 22160394:193:372
status: NEW220 Moreover, block by neither drug was affected by mutations T351A or Q353A, suggesting that these sites do not contribute to the region comprising the anion selectivity filter as previously suggested [9, 20].
X
ABCC7 p.Thr351Ala 22160394:220:58
status: NEW